nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—SRD5A1—type 2 diabetes mellitus	0.484	0.895	CbGaD
Finasteride—CYP3A4—type 2 diabetes mellitus	0.0565	0.104	CbGaD
Finasteride—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0368	0.14	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0368	0.14	CbGbCtD
Finasteride—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0276	0.105	CbGbCtD
Finasteride—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.022	0.0838	CbGbCtD
Finasteride—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0196	0.0747	CbGbCtD
Finasteride—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0179	0.0683	CbGbCtD
Finasteride—CYP3A5—Losartan—type 2 diabetes mellitus	0.017	0.0649	CbGbCtD
Finasteride—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0157	0.0597	CbGbCtD
Finasteride—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0142	0.054	CbGbCtD
Finasteride—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0108	0.0409	CbGbCtD
Finasteride—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0103	0.0393	CbGbCtD
Finasteride—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0103	0.0393	CbGbCtD
Finasteride—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00975	0.0371	CbGbCtD
Finasteride—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00726	0.0277	CbGbCtD
Finasteride—CYP3A4—Losartan—type 2 diabetes mellitus	0.00664	0.0253	CbGbCtD
Finasteride—Dutasteride—SRD5A1—type 2 diabetes mellitus	0.00268	0.552	CrCbGaD
Finasteride—Rash—Miglitol—type 2 diabetes mellitus	0.000395	0.0038	CcSEcCtD
Finasteride—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000395	0.0038	CcSEcCtD
Finasteride—Breast disorder—Orlistat—type 2 diabetes mellitus	0.000392	0.00378	CcSEcCtD
Finasteride—Urticaria—Acarbose—type 2 diabetes mellitus	0.000391	0.00377	CcSEcCtD
Finasteride—Mental disorder—Sitagliptin—type 2 diabetes mellitus	0.00039	0.00375	CcSEcCtD
Finasteride—Injury—Losartan—type 2 diabetes mellitus	0.000387	0.00372	CcSEcCtD
Finasteride—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000386	0.00371	CcSEcCtD
Finasteride—Libido decreased—Losartan—type 2 diabetes mellitus	0.000383	0.00369	CcSEcCtD
Finasteride—Erectile dysfunction—Gliclazide—type 2 diabetes mellitus	0.000381	0.00366	CcSEcCtD
Finasteride—Urticaria—Nateglinide—type 2 diabetes mellitus	0.000377	0.00363	CcSEcCtD
Finasteride—Drostanolone—SHBG—type 2 diabetes mellitus	0.000377	0.0776	CrCbGaD
Finasteride—Gynaecomastia—Ramipril—type 2 diabetes mellitus	0.000376	0.00361	CcSEcCtD
Finasteride—Influenza—Orlistat—type 2 diabetes mellitus	0.000375	0.00361	CcSEcCtD
Finasteride—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.000374	0.0036	CcSEcCtD
Finasteride—Asthenia—Tolazamide—type 2 diabetes mellitus	0.000368	0.00354	CcSEcCtD
Finasteride—Bronchitis—Valsartan—type 2 diabetes mellitus	0.000365	0.00351	CcSEcCtD
Finasteride—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.000365	0.00351	CcSEcCtD
Finasteride—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.000363	0.00349	CcSEcCtD
Finasteride—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000363	0.00349	CcSEcCtD
Finasteride—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000363	0.00349	CcSEcCtD
Finasteride—Breast disorder—Metformin—type 2 diabetes mellitus	0.000362	0.00348	CcSEcCtD
Finasteride—Angioedema—Glimepiride—type 2 diabetes mellitus	0.000355	0.00342	CcSEcCtD
Finasteride—Rash—Tolbutamide—type 2 diabetes mellitus	0.000355	0.00342	CcSEcCtD
Finasteride—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.000354	0.00341	CcSEcCtD
Finasteride—Mental disorder—Bromocriptine—type 2 diabetes mellitus	0.000353	0.0034	CcSEcCtD
Finasteride—Headache—Tolbutamide—type 2 diabetes mellitus	0.000353	0.0034	CcSEcCtD
Finasteride—Disturbance in sexual arousal—Losartan—type 2 diabetes mellitus	0.000353	0.00339	CcSEcCtD
Finasteride—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00035	0.00337	CcSEcCtD
Finasteride—Erectile dysfunction—Valsartan—type 2 diabetes mellitus	0.00035	0.00337	CcSEcCtD
Finasteride—Influenza—Metformin—type 2 diabetes mellitus	0.000346	0.00333	CcSEcCtD
Finasteride—Sinusitis—Gliclazide—type 2 diabetes mellitus	0.000346	0.00333	CcSEcCtD
Finasteride—Orthostatic hypotension—Irbesartan—type 2 diabetes mellitus	0.000345	0.00332	CcSEcCtD
Finasteride—Breast disorder—Irbesartan—type 2 diabetes mellitus	0.000341	0.00328	CcSEcCtD
Finasteride—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000341	0.00328	CcSEcCtD
Finasteride—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000339	0.00326	CcSEcCtD
Finasteride—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000339	0.00326	CcSEcCtD
Finasteride—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000336	0.00323	CcSEcCtD
Finasteride—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.000332	0.00319	CcSEcCtD
Finasteride—Drostanolone—AR—type 2 diabetes mellitus	0.00033	0.068	CrCbGaD
Finasteride—Libido decreased—Ramipril—type 2 diabetes mellitus	0.000329	0.00316	CcSEcCtD
Finasteride—Pharyngitis—Gliclazide—type 2 diabetes mellitus	0.000328	0.00316	CcSEcCtD
Finasteride—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000327	0.00314	CcSEcCtD
Finasteride—Influenza—Irbesartan—type 2 diabetes mellitus	0.000326	0.00314	CcSEcCtD
Finasteride—Oedema peripheral—Gliclazide—type 2 diabetes mellitus	0.000326	0.00314	CcSEcCtD
Finasteride—Orthostatic hypotension—Losartan—type 2 diabetes mellitus	0.000325	0.00312	CcSEcCtD
Finasteride—Infection—Pioglitazone—type 2 diabetes mellitus	0.000324	0.00311	CcSEcCtD
Finasteride—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000323	0.00311	CcSEcCtD
Finasteride—Rash—Tolazamide—type 2 diabetes mellitus	0.000323	0.00311	CcSEcCtD
Finasteride—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000321	0.00309	CcSEcCtD
Finasteride—Headache—Tolazamide—type 2 diabetes mellitus	0.000321	0.00309	CcSEcCtD
Finasteride—Breast disorder—Losartan—type 2 diabetes mellitus	0.000321	0.00309	CcSEcCtD
Finasteride—Rash—Linagliptin—type 2 diabetes mellitus	0.00032	0.00308	CcSEcCtD
Finasteride—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00032	0.00308	CcSEcCtD
Finasteride—Headache—Linagliptin—type 2 diabetes mellitus	0.000318	0.00306	CcSEcCtD
Finasteride—Sinusitis—Valsartan—type 2 diabetes mellitus	0.000318	0.00306	CcSEcCtD
Finasteride—Infection—Sitagliptin—type 2 diabetes mellitus	0.000314	0.00302	CcSEcCtD
Finasteride—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000314	0.00302	CcSEcCtD
Finasteride—Sinusitis—Orlistat—type 2 diabetes mellitus	0.000314	0.00302	CcSEcCtD
Finasteride—Dutasteride—CYP3A4—type 2 diabetes mellitus	0.000313	0.0644	CrCbGaD
Finasteride—Rash—Acarbose—type 2 diabetes mellitus	0.000311	0.00299	CcSEcCtD
Finasteride—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00031	0.00299	CcSEcCtD
Finasteride—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000309	0.00297	CcSEcCtD
Finasteride—Influenza—Losartan—type 2 diabetes mellitus	0.000307	0.00296	CcSEcCtD
Finasteride—Rhinitis—Valsartan—type 2 diabetes mellitus	0.000305	0.00293	CcSEcCtD
Finasteride—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000303	0.00292	CcSEcCtD
Finasteride—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000303	0.00291	CcSEcCtD
Finasteride—Somnolence—Glipizide—type 2 diabetes mellitus	0.000302	0.00291	CcSEcCtD
Finasteride—Disturbance in sexual arousal—Ramipril—type 2 diabetes mellitus	0.000302	0.00291	CcSEcCtD
Finasteride—Pharyngitis—Valsartan—type 2 diabetes mellitus	0.000302	0.0029	CcSEcCtD
Finasteride—Rash—Nateglinide—type 2 diabetes mellitus	0.000299	0.00288	CcSEcCtD
Finasteride—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000299	0.00288	CcSEcCtD
Finasteride—Pharyngitis—Orlistat—type 2 diabetes mellitus	0.000298	0.00287	CcSEcCtD
Finasteride—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000297	0.00285	CcSEcCtD
Finasteride—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.000296	0.00285	CcSEcCtD
Finasteride—Bronchitis—Losartan—type 2 diabetes mellitus	0.000295	0.00284	CcSEcCtD
Finasteride—Angioedema—Glyburide—type 2 diabetes mellitus	0.000293	0.00282	CcSEcCtD
Finasteride—Pain—Glipizide—type 2 diabetes mellitus	0.000291	0.0028	CcSEcCtD
Finasteride—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000291	0.0028	CcSEcCtD
Finasteride—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00029	0.0028	CcSEcCtD
Finasteride—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.00029	0.00279	CcSEcCtD
Finasteride—Infection—Bromocriptine—type 2 diabetes mellitus	0.000284	0.00274	CcSEcCtD
Finasteride—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000283	0.00272	CcSEcCtD
Finasteride—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.000283	0.00272	CcSEcCtD
Finasteride—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000282	0.00272	CcSEcCtD
Finasteride—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000281	0.00271	CcSEcCtD
Finasteride—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000279	0.00268	CcSEcCtD
Finasteride—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000278	0.00268	CcSEcCtD
Finasteride—Rhinitis—Metformin—type 2 diabetes mellitus	0.000277	0.00267	CcSEcCtD
Finasteride—Breast disorder—Ramipril—type 2 diabetes mellitus	0.000275	0.00265	CcSEcCtD
Finasteride—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000275	0.00265	CcSEcCtD
Finasteride—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000275	0.00264	CcSEcCtD
Finasteride—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000273	0.00262	CcSEcCtD
Finasteride—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000271	0.00261	CcSEcCtD
Finasteride—Pain—Sitagliptin—type 2 diabetes mellitus	0.000271	0.0026	CcSEcCtD
Finasteride—Urticaria—Glipizide—type 2 diabetes mellitus	0.00027	0.0026	CcSEcCtD
Finasteride—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000268	0.00257	CcSEcCtD
Finasteride—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000266	0.00256	CcSEcCtD
Finasteride—Influenza—Ramipril—type 2 diabetes mellitus	0.000263	0.00253	CcSEcCtD
Finasteride—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000263	0.00253	CcSEcCtD
Finasteride—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000263	0.00253	CcSEcCtD
Finasteride—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000262	0.00252	CcSEcCtD
Finasteride—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000259	0.00249	CcSEcCtD
Finasteride—Rash—Repaglinide—type 2 diabetes mellitus	0.000259	0.00249	CcSEcCtD
Finasteride—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000259	0.00249	CcSEcCtD
Finasteride—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000259	0.00249	CcSEcCtD
Finasteride—Headache—Repaglinide—type 2 diabetes mellitus	0.000258	0.00248	CcSEcCtD
Finasteride—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000257	0.00248	CcSEcCtD
Finasteride—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000257	0.00247	CcSEcCtD
Finasteride—Sinusitis—Losartan—type 2 diabetes mellitus	0.000257	0.00247	CcSEcCtD
Finasteride—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000255	0.00246	CcSEcCtD
Finasteride—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000255	0.00245	CcSEcCtD
Finasteride—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000253	0.00244	CcSEcCtD
Finasteride—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000252	0.00243	CcSEcCtD
Finasteride—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000251	0.00242	CcSEcCtD
Finasteride—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000251	0.00241	CcSEcCtD
Finasteride—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00025	0.00241	CcSEcCtD
Finasteride—Rhinitis—Losartan—type 2 diabetes mellitus	0.000246	0.00237	CcSEcCtD
Finasteride—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000245	0.00236	CcSEcCtD
Finasteride—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000245	0.00236	CcSEcCtD
Finasteride—Hypotension—Glyburide—type 2 diabetes mellitus	0.000245	0.00235	CcSEcCtD
Finasteride—Asthenia—Glipizide—type 2 diabetes mellitus	0.000244	0.00235	CcSEcCtD
Finasteride—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000244	0.00235	CcSEcCtD
Finasteride—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000243	0.00234	CcSEcCtD
Finasteride—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000243	0.00233	CcSEcCtD
Finasteride—Angioedema—Valsartan—type 2 diabetes mellitus	0.000242	0.00233	CcSEcCtD
Finasteride—Pruritus—Glipizide—type 2 diabetes mellitus	0.000241	0.00232	CcSEcCtD
Finasteride—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00024	0.00231	CcSEcCtD
Finasteride—Angioedema—Orlistat—type 2 diabetes mellitus	0.000239	0.0023	CcSEcCtD
Finasteride—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000236	0.00227	CcSEcCtD
Finasteride—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000234	0.00225	CcSEcCtD
Finasteride—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000234	0.00225	CcSEcCtD
Finasteride—Infection—Gliclazide—type 2 diabetes mellitus	0.000234	0.00225	CcSEcCtD
Finasteride—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000233	0.00225	CcSEcCtD
Finasteride—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000233	0.00224	CcSEcCtD
Finasteride—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000228	0.00219	CcSEcCtD
Finasteride—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000227	0.00219	CcSEcCtD
Finasteride—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00218	CcSEcCtD
Finasteride—Dizziness—Glipizide—type 2 diabetes mellitus	0.000225	0.00216	CcSEcCtD
Finasteride—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000225	0.00216	CcSEcCtD
Finasteride—Sinusitis—Ramipril—type 2 diabetes mellitus	0.00022	0.00212	CcSEcCtD
Finasteride—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00022	0.00211	CcSEcCtD
Finasteride—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000215	0.00207	CcSEcCtD
Finasteride—Infection—Valsartan—type 2 diabetes mellitus	0.000215	0.00206	CcSEcCtD
Finasteride—Rash—Glipizide—type 2 diabetes mellitus	0.000214	0.00206	CcSEcCtD
Finasteride—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000214	0.00206	CcSEcCtD
Finasteride—Headache—Glipizide—type 2 diabetes mellitus	0.000213	0.00205	CcSEcCtD
Finasteride—Infection—Orlistat—type 2 diabetes mellitus	0.000212	0.00204	CcSEcCtD
Finasteride—Medrysone—NR3C1—type 2 diabetes mellitus	0.000211	0.0434	CrCbGaD
Finasteride—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00021	0.00202	CcSEcCtD
Finasteride—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00021	0.00202	CcSEcCtD
Finasteride—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000209	0.00201	CcSEcCtD
Finasteride—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000209	0.00201	CcSEcCtD
Finasteride—Urticaria—Glyburide—type 2 diabetes mellitus	0.000208	0.002	CcSEcCtD
Finasteride—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000208	0.002	CcSEcCtD
Finasteride—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000208	0.002	CcSEcCtD
Finasteride—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00198	CcSEcCtD
Finasteride—Headache—Pioglitazone—type 2 diabetes mellitus	0.000204	0.00196	CcSEcCtD
Finasteride—Hypotension—Valsartan—type 2 diabetes mellitus	0.000202	0.00194	CcSEcCtD
Finasteride—Testosterone Propionate—AR—type 2 diabetes mellitus	0.000201	0.0415	CrCbGaD
Finasteride—Pain—Gliclazide—type 2 diabetes mellitus	0.000201	0.00193	CcSEcCtD
Finasteride—Rash—Glimepiride—type 2 diabetes mellitus	0.0002	0.00193	CcSEcCtD
Finasteride—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.0002	0.00192	CcSEcCtD
Finasteride—Rash—Sitagliptin—type 2 diabetes mellitus	0.000199	0.00192	CcSEcCtD
Finasteride—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000199	0.00192	CcSEcCtD
Finasteride—Headache—Glimepiride—type 2 diabetes mellitus	0.000199	0.00191	CcSEcCtD
Finasteride—Headache—Sitagliptin—type 2 diabetes mellitus	0.000198	0.00191	CcSEcCtD
Finasteride—Angioedema—Losartan—type 2 diabetes mellitus	0.000196	0.00188	CcSEcCtD
Finasteride—Infection—Metformin—type 2 diabetes mellitus	0.000195	0.00188	CcSEcCtD
Finasteride—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000193	0.00186	CcSEcCtD
Finasteride—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000193	0.00185	CcSEcCtD
Finasteride—Somnolence—Valsartan—type 2 diabetes mellitus	0.000192	0.00185	CcSEcCtD
Finasteride—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00019	0.00183	CcSEcCtD
Finasteride—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000189	0.00182	CcSEcCtD
Finasteride—Asthenia—Glyburide—type 2 diabetes mellitus	0.000188	0.00181	CcSEcCtD
Finasteride—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000187	0.0018	CcSEcCtD
Finasteride—Pruritus—Glyburide—type 2 diabetes mellitus	0.000185	0.00178	CcSEcCtD
Finasteride—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000185	0.00178	CcSEcCtD
Finasteride—Infection—Irbesartan—type 2 diabetes mellitus	0.000184	0.00177	CcSEcCtD
Finasteride—Hypotension—Metformin—type 2 diabetes mellitus	0.000184	0.00177	CcSEcCtD
Finasteride—Pain—Orlistat—type 2 diabetes mellitus	0.000182	0.00176	CcSEcCtD
Finasteride—Rash—Bromocriptine—type 2 diabetes mellitus	0.000181	0.00174	CcSEcCtD
Finasteride—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00018	0.00174	CcSEcCtD
Finasteride—Headache—Bromocriptine—type 2 diabetes mellitus	0.000179	0.00173	CcSEcCtD
Finasteride—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000175	0.00169	CcSEcCtD
Finasteride—Somnolence—Metformin—type 2 diabetes mellitus	0.000175	0.00168	CcSEcCtD
Finasteride—Infection—Losartan—type 2 diabetes mellitus	0.000174	0.00167	CcSEcCtD
Finasteride—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000173	0.00167	CcSEcCtD
Finasteride—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000173	0.00167	CcSEcCtD
Finasteride—Urticaria—Valsartan—type 2 diabetes mellitus	0.000172	0.00165	CcSEcCtD
Finasteride—Urticaria—Orlistat—type 2 diabetes mellitus	0.00017	0.00163	CcSEcCtD
Finasteride—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000169	0.00162	CcSEcCtD
Finasteride—Angioedema—Ramipril—type 2 diabetes mellitus	0.000168	0.00161	CcSEcCtD
Finasteride—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000166	0.0016	CcSEcCtD
Finasteride—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000165	0.00159	CcSEcCtD
Finasteride—Rash—Glyburide—type 2 diabetes mellitus	0.000165	0.00159	CcSEcCtD
Finasteride—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000165	0.00159	CcSEcCtD
Finasteride—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000165	0.00159	CcSEcCtD
Finasteride—Headache—Glyburide—type 2 diabetes mellitus	0.000164	0.00158	CcSEcCtD
Finasteride—Hypotension—Losartan—type 2 diabetes mellitus	0.000163	0.00157	CcSEcCtD
Finasteride—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000159	0.00153	CcSEcCtD
Finasteride—Pain—Irbesartan—type 2 diabetes mellitus	0.000159	0.00153	CcSEcCtD
Finasteride—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000157	0.00151	CcSEcCtD
Finasteride—Urticaria—Metformin—type 2 diabetes mellitus	0.000156	0.0015	CcSEcCtD
Finasteride—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000156	0.0015	CcSEcCtD
Finasteride—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000155	0.0015	CcSEcCtD
Finasteride—Somnolence—Losartan—type 2 diabetes mellitus	0.000155	0.00149	CcSEcCtD
Finasteride—Asthenia—Valsartan—type 2 diabetes mellitus	0.000155	0.00149	CcSEcCtD
Finasteride—Asthenia—Orlistat—type 2 diabetes mellitus	0.000153	0.00147	CcSEcCtD
Finasteride—Pruritus—Valsartan—type 2 diabetes mellitus	0.000153	0.00147	CcSEcCtD
Finasteride—Pruritus—Orlistat—type 2 diabetes mellitus	0.000151	0.00145	CcSEcCtD
Finasteride—Pain—Losartan—type 2 diabetes mellitus	0.000149	0.00144	CcSEcCtD
Finasteride—Rash—Gliclazide—type 2 diabetes mellitus	0.000148	0.00143	CcSEcCtD
Finasteride—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000148	0.00142	CcSEcCtD
Finasteride—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000147	0.00142	CcSEcCtD
Finasteride—Headache—Gliclazide—type 2 diabetes mellitus	0.000147	0.00142	CcSEcCtD
Finasteride—Dizziness—Valsartan—type 2 diabetes mellitus	0.000143	0.00137	CcSEcCtD
Finasteride—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000142	0.0291	CrCbGaD
Finasteride—Dizziness—Orlistat—type 2 diabetes mellitus	0.000141	0.00136	CcSEcCtD
Finasteride—Asthenia—Metformin—type 2 diabetes mellitus	0.000141	0.00136	CcSEcCtD
Finasteride—Hypotension—Ramipril—type 2 diabetes mellitus	0.00014	0.00135	CcSEcCtD
Finasteride—Pruritus—Metformin—type 2 diabetes mellitus	0.000139	0.00134	CcSEcCtD
Finasteride—Urticaria—Losartan—type 2 diabetes mellitus	0.000139	0.00134	CcSEcCtD
Finasteride—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000137	0.00132	CcSEcCtD
Finasteride—Rash—Valsartan—type 2 diabetes mellitus	0.000136	0.00131	CcSEcCtD
Finasteride—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000136	0.00131	CcSEcCtD
Finasteride—Headache—Valsartan—type 2 diabetes mellitus	0.000135	0.0013	CcSEcCtD
Finasteride—Rash—Orlistat—type 2 diabetes mellitus	0.000135	0.00129	CcSEcCtD
Finasteride—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000134	0.00129	CcSEcCtD
Finasteride—Headache—Orlistat—type 2 diabetes mellitus	0.000134	0.00129	CcSEcCtD
Finasteride—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000134	0.00128	CcSEcCtD
Finasteride—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000133	0.00128	CcSEcCtD
Finasteride—Somnolence—Ramipril—type 2 diabetes mellitus	0.000133	0.00128	CcSEcCtD
Finasteride—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000131	0.00126	CcSEcCtD
Finasteride—Dizziness—Metformin—type 2 diabetes mellitus	0.00013	0.00125	CcSEcCtD
Finasteride—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000129	0.00124	CcSEcCtD
Finasteride—Asthenia—Losartan—type 2 diabetes mellitus	0.000125	0.00121	CcSEcCtD
Finasteride—Rash—Metformin—type 2 diabetes mellitus	0.000124	0.00119	CcSEcCtD
Finasteride—Dermatitis—Metformin—type 2 diabetes mellitus	0.000124	0.00119	CcSEcCtD
Finasteride—Pruritus—Losartan—type 2 diabetes mellitus	0.000124	0.00119	CcSEcCtD
Finasteride—Headache—Metformin—type 2 diabetes mellitus	0.000123	0.00119	CcSEcCtD
Finasteride—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000123	0.00118	CcSEcCtD
Finasteride—Urticaria—Ramipril—type 2 diabetes mellitus	0.000119	0.00114	CcSEcCtD
Finasteride—Rash—Irbesartan—type 2 diabetes mellitus	0.000117	0.00113	CcSEcCtD
Finasteride—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000117	0.00112	CcSEcCtD
Finasteride—Headache—Irbesartan—type 2 diabetes mellitus	0.000116	0.00112	CcSEcCtD
Finasteride—Dizziness—Losartan—type 2 diabetes mellitus	0.000115	0.00111	CcSEcCtD
Finasteride—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00011	0.00106	CcSEcCtD
Finasteride—Rash—Losartan—type 2 diabetes mellitus	0.00011	0.00106	CcSEcCtD
Finasteride—Dermatitis—Losartan—type 2 diabetes mellitus	0.00011	0.00106	CcSEcCtD
Finasteride—Headache—Losartan—type 2 diabetes mellitus	0.000109	0.00105	CcSEcCtD
Finasteride—Asthenia—Ramipril—type 2 diabetes mellitus	0.000107	0.00103	CcSEcCtD
Finasteride—Pruritus—Ramipril—type 2 diabetes mellitus	0.000106	0.00102	CcSEcCtD
Finasteride—Progesterone—SHBG—type 2 diabetes mellitus	0.000105	0.0217	CrCbGaD
Finasteride—Testosterone—SHBG—type 2 diabetes mellitus	9.97e-05	0.0205	CrCbGaD
Finasteride—Dizziness—Ramipril—type 2 diabetes mellitus	9.9e-05	0.000953	CcSEcCtD
Finasteride—Rash—Ramipril—type 2 diabetes mellitus	9.44e-05	0.000909	CcSEcCtD
Finasteride—Dermatitis—Ramipril—type 2 diabetes mellitus	9.43e-05	0.000908	CcSEcCtD
Finasteride—Headache—Ramipril—type 2 diabetes mellitus	9.38e-05	0.000903	CcSEcCtD
Finasteride—Progesterone—AR—type 2 diabetes mellitus	9.25e-05	0.019	CrCbGaD
Finasteride—Testosterone—AR—type 2 diabetes mellitus	8.74e-05	0.018	CrCbGaD
Finasteride—Progesterone—NR3C1—type 2 diabetes mellitus	6.27e-05	0.0129	CrCbGaD
Finasteride—Progesterone—CYP1A2—type 2 diabetes mellitus	5.49e-05	0.0113	CrCbGaD
Finasteride—Progesterone—CYP3A4—type 2 diabetes mellitus	3.64e-05	0.00749	CrCbGaD
Finasteride—Testosterone—CYP3A4—type 2 diabetes mellitus	3.44e-05	0.00708	CrCbGaD
Finasteride—Testosterone—ALB—type 2 diabetes mellitus	3e-05	0.00617	CrCbGaD
Finasteride—CYP3A7—Metabolism—ENPP1—type 2 diabetes mellitus	2.12e-05	0.000241	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ND1—type 2 diabetes mellitus	2.12e-05	0.000241	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	2.11e-05	0.000241	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	2.09e-05	0.000237	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ALB—type 2 diabetes mellitus	2.05e-05	0.000233	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GCGR—type 2 diabetes mellitus	2.05e-05	0.000233	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.01e-05	0.000229	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.01e-05	0.000229	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—NOS3—type 2 diabetes mellitus	1.96e-05	0.000223	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.96e-05	0.000223	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYTB—type 2 diabetes mellitus	1.93e-05	0.00022	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—OXCT1—type 2 diabetes mellitus	1.93e-05	0.00022	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AANAT—type 2 diabetes mellitus	1.9e-05	0.000216	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTGDS—type 2 diabetes mellitus	1.9e-05	0.000216	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SRD5A1—type 2 diabetes mellitus	1.89e-05	0.000214	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ACACA—type 2 diabetes mellitus	1.8e-05	0.000205	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—STAR—type 2 diabetes mellitus	1.8e-05	0.000205	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HSD17B3—type 2 diabetes mellitus	1.8e-05	0.000205	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GPD2—type 2 diabetes mellitus	1.8e-05	0.000205	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CDO1—type 2 diabetes mellitus	1.8e-05	0.000205	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PTGS2—type 2 diabetes mellitus	1.79e-05	0.000204	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	1.75e-05	0.000199	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	1.73e-05	0.000196	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ABCC8—type 2 diabetes mellitus	1.72e-05	0.000196	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CBS—type 2 diabetes mellitus	1.72e-05	0.000196	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	1.72e-05	0.000196	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AK1—type 2 diabetes mellitus	1.72e-05	0.000195	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	1.7e-05	0.000194	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC5A2—type 2 diabetes mellitus	1.66e-05	0.000189	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—COX2—type 2 diabetes mellitus	1.66e-05	0.000189	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NCOA6—type 2 diabetes mellitus	1.63e-05	0.000185	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—UCP3—type 2 diabetes mellitus	1.6e-05	0.000182	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HSD11B1—type 2 diabetes mellitus	1.6e-05	0.000182	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—UCP2—type 2 diabetes mellitus	1.6e-05	0.000182	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC5A4—type 2 diabetes mellitus	1.58e-05	0.00018	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MAT1A—type 2 diabetes mellitus	1.58e-05	0.00018	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ND1—type 2 diabetes mellitus	1.53e-05	0.000174	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ENPP1—type 2 diabetes mellitus	1.53e-05	0.000174	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—G6PC—type 2 diabetes mellitus	1.53e-05	0.000174	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.53e-05	0.000174	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HBA2—type 2 diabetes mellitus	1.53e-05	0.000174	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PCK1—type 2 diabetes mellitus	1.51e-05	0.000171	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GCGR—type 2 diabetes mellitus	1.48e-05	0.000168	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HK1—type 2 diabetes mellitus	1.41e-05	0.000161	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—OXCT1—type 2 diabetes mellitus	1.4e-05	0.000159	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYTB—type 2 diabetes mellitus	1.4e-05	0.000159	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GCKR—type 2 diabetes mellitus	1.36e-05	0.000155	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—KCNJ11—type 2 diabetes mellitus	1.36e-05	0.000155	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HSD3B2—type 2 diabetes mellitus	1.36e-05	0.000155	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—LPA—type 2 diabetes mellitus	1.36e-05	0.000155	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SRD5A1—type 2 diabetes mellitus	1.36e-05	0.000155	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.32e-05	0.00015	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALDOB—type 2 diabetes mellitus	1.31e-05	0.000149	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.3e-05	0.000148	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HSD17B3—type 2 diabetes mellitus	1.3e-05	0.000148	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ACACA—type 2 diabetes mellitus	1.3e-05	0.000148	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—STAR—type 2 diabetes mellitus	1.3e-05	0.000148	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CBS—type 2 diabetes mellitus	1.25e-05	0.000142	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ABCC8—type 2 diabetes mellitus	1.25e-05	0.000142	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GLP1R—type 2 diabetes mellitus	1.21e-05	0.000138	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—COX2—type 2 diabetes mellitus	1.2e-05	0.000136	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC5A2—type 2 diabetes mellitus	1.2e-05	0.000136	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NCOA6—type 2 diabetes mellitus	1.18e-05	0.000134	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—UCP2—type 2 diabetes mellitus	1.16e-05	0.000132	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HSD11B1—type 2 diabetes mellitus	1.16e-05	0.000132	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—UCP3—type 2 diabetes mellitus	1.16e-05	0.000132	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC2A2—type 2 diabetes mellitus	1.13e-05	0.000129	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MTR—type 2 diabetes mellitus	1.11e-05	0.000126	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CPT1A—type 2 diabetes mellitus	1.11e-05	0.000126	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NAMPT—type 2 diabetes mellitus	1.09e-05	0.000124	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PCK1—type 2 diabetes mellitus	1.09e-05	0.000124	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GCK—type 2 diabetes mellitus	1.08e-05	0.000123	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HBA1—type 2 diabetes mellitus	1.08e-05	0.000123	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—LIPC—type 2 diabetes mellitus	1.08e-05	0.000123	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP11A1—type 2 diabetes mellitus	1.08e-05	0.000122	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC9A1—type 2 diabetes mellitus	1.06e-05	0.00012	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CETP—type 2 diabetes mellitus	1.04e-05	0.000119	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HK1—type 2 diabetes mellitus	1.02e-05	0.000116	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-05	0.000115	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—AKT1—type 2 diabetes mellitus	1.01e-05	0.000115	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.01e-05	0.000115	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HSD3B2—type 2 diabetes mellitus	9.85e-06	0.000112	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—KCNJ11—type 2 diabetes mellitus	9.85e-06	0.000112	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GCKR—type 2 diabetes mellitus	9.85e-06	0.000112	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—LPA—type 2 diabetes mellitus	9.85e-06	0.000112	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SREBF1—type 2 diabetes mellitus	9.71e-06	0.00011	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PSMD6—type 2 diabetes mellitus	9.71e-06	0.00011	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SNAP25—type 2 diabetes mellitus	9.71e-06	0.00011	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CTGF—type 2 diabetes mellitus	9.53e-06	0.000108	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HMGCR—type 2 diabetes mellitus	9.45e-06	0.000107	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALDOB—type 2 diabetes mellitus	9.45e-06	0.000107	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ADRA2A—type 2 diabetes mellitus	9.25e-06	0.000105	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—AKT1—type 2 diabetes mellitus	9.02e-06	0.000103	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP2E1—type 2 diabetes mellitus	8.88e-06	0.000101	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	8.82e-06	0.0001	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	8.82e-06	0.0001	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP1A2—type 2 diabetes mellitus	8.78e-06	9.99e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC2A1—type 2 diabetes mellitus	8.78e-06	9.99e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	8.78e-06	9.99e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP3A4—type 2 diabetes mellitus	8.57e-06	9.74e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC2A4—type 2 diabetes mellitus	8.42e-06	9.58e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GCG—type 2 diabetes mellitus	8.42e-06	9.58e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	8.36e-06	9.51e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	8.36e-06	9.51e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	8.2e-06	9.33e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	8.03e-06	9.14e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	8.03e-06	9.14e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	7.98e-06	9.07e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	7.88e-06	8.96e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	7.83e-06	8.9e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	7.83e-06	8.9e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	7.83e-06	8.9e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	7.78e-06	8.85e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	7.64e-06	8.69e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	7.55e-06	8.59e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	7.36e-06	8.37e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	7.36e-06	8.37e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.26e-06	8.26e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GNB3—type 2 diabetes mellitus	7.26e-06	8.26e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HMOX1—type 2 diabetes mellitus	7.23e-06	8.22e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CAT—type 2 diabetes mellitus	7.13e-06	8.11e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.11e-06	8.09e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.11e-06	8.09e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.11e-06	8.09e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.11e-06	8.09e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.11e-06	8.09e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	7.02e-06	7.99e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	7.02e-06	7.99e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	7.02e-06	7.99e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—APOB—type 2 diabetes mellitus	6.92e-06	7.87e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	6.89e-06	7.84e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	6.89e-06	7.83e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	6.83e-06	7.77e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GSTM1—type 2 diabetes mellitus	6.73e-06	7.66e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	6.68e-06	7.6e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	6.61e-06	7.52e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.5e-06	7.4e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.5e-06	7.4e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	6.47e-06	7.36e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	6.45e-06	7.33e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	6.42e-06	7.3e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	6.35e-06	7.22e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	6.35e-06	7.22e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.34e-06	7.21e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	6.28e-06	7.14e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	6.2e-06	7.05e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	6.19e-06	7.04e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	6.09e-06	6.92e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	6.09e-06	6.92e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.04e-06	6.88e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.04e-06	6.88e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.04e-06	6.88e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	5.95e-06	6.77e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	5.84e-06	6.64e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.8e-06	6.59e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.8e-06	6.59e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	5.65e-06	6.43e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.58e-06	6.35e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.58e-06	6.35e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	5.56e-06	6.32e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	5.54e-06	6.3e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.48e-06	6.23e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	5.48e-06	6.23e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.39e-06	6.13e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.39e-06	6.13e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.39e-06	6.13e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.25e-06	5.97e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	5.25e-06	5.97e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	5.22e-06	5.94e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	5.15e-06	5.86e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.07e-06	5.76e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	5e-06	5.69e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	4.87e-06	5.54e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	4.82e-06	5.49e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	4.78e-06	5.43e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.74e-06	5.4e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	4.73e-06	5.38e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.68e-06	5.32e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.66e-06	5.3e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.58e-06	5.21e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.58e-06	5.21e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.58e-06	5.21e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.58e-06	5.21e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.54e-06	5.16e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.48e-06	5.1e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.39e-06	5e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.34e-06	4.93e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.3e-06	4.89e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.22e-06	4.8e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.15e-06	4.72e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.15e-06	4.72e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.09e-06	4.65e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.08e-06	4.64e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.02e-06	4.57e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4e-06	4.55e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	3.96e-06	4.5e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.81e-06	4.34e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	3.8e-06	4.32e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.73e-06	4.25e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.73e-06	4.25e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.66e-06	4.17e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.64e-06	4.14e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.64e-06	4.14e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.64e-06	4.14e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.62e-06	4.11e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.55e-06	4.04e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.51e-06	3.99e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.49e-06	3.97e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.42e-06	3.89e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.26e-06	3.71e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.26e-06	3.71e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.26e-06	3.71e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.2e-06	3.64e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.18e-06	3.61e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.14e-06	3.57e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.11e-06	3.53e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3e-06	3.41e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3e-06	3.41e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.99e-06	3.4e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.95e-06	3.36e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.95e-06	3.36e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.83e-06	3.22e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.83e-06	3.22e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.74e-06	3.12e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.44e-06	2.77e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.44e-06	2.77e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.43e-06	2.76e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.4e-06	2.73e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.33e-06	2.65e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.26e-06	2.57e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.22e-06	2.53e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.17e-06	2.47e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.17e-06	2.46e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.11e-06	2.4e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.08e-06	2.37e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2e-06	2.27e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.96e-06	2.23e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	1.91e-06	2.17e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.9e-06	2.16e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.87e-06	2.12e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.86e-06	2.12e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.84e-06	2.09e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.62e-06	1.84e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.59e-06	1.81e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.46e-06	1.66e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.39e-06	1.59e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.39e-06	1.59e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.38e-06	1.57e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.28e-06	1.45e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.41e-07	7.29e-06	CbGpPWpGaD
